Streamlining Sponsor’s Nonclinical & SEND Outsourcing to CROs
March 20, 2019
PointCross Testing
PointCross Live Discussion – Recent Regulatory and Standards Updates
Kavan Palangappa2026-05-07T09:03:35+00:00Recent FDA Regulatory and Standards UpdatesTuesday, December 11th, 2018
Integrating Clinical, Biomarker & Disparate Data
Kavan Palangappa2024-06-14T06:11:37+00:00Title: How to Integrate Clinical, Biomarker, and Other Disparate Data Sources May 16, 2017
What does SEND Readiness mean for your company? – Webinar
Kavan Palangappa2026-05-07T09:16:46+00:00What does SEND Readiness mean for your company The FDA will soon require drug companies to transmit their nonclinical data submissions in standardized electronic formats like SEND. This will fundamentally impact workflows and data management within drug companies and CROs, and will require nonclinical toxicologists to become conversant with new ways of representing their data....